Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
CANCER:
Ganglioglioma
Associations
(11)
News
Trials
A2 | Sensitive
C1 | Sensitive
C3 | Sensitive
C4 | Sensitive
A2 | Resistant
C1 | Resistant
C3 | Resistant
C4 | Resistant
Show legend
Group by Gene:
Drug categories
Serine-Threonine Kinase Inhibitors
Threonine-Tyrosine Kinase Inhibitors
Cancel
MEK1 inhibitor
cobimetinib
MEK inhibitor, BRAF inhibitor
trametinib + dabrafenib
BRAF inhibitor + MEK inhibitor
BRAF inhibitor, BRAF V600E inhibitor
vemurafenib
BRAF inhibitor
dabrafenib
MEK inhibitor
trametinib
BRAF inhibitor, MEK1 inhibitor, BRAF V600E inhibitor
vemurafenib + cobimetinib
BRAF V600E
A2
BRAF V600E
|
Ganglioglioma
|
cobimetinib
A2
BRAF V600E
|
Ganglioglioma
|
trametinib + dabrafenib
A2
BRAF V600E
|
Ganglioglioma
|
vemurafenib
A2
BRAF V600E
|
Ganglioglioma
|
dabrafenib
A2
BRAF V600E
|
Ganglioglioma
|
trametinib
A2
BRAF V600E
|
Ganglioglioma
|
vemurafenib + cobimetinib
BRAF V600
C1
BRAF V600
|
Ganglioglioma
|
trametinib + dabrafenib
C3
BRAF V600
|
Ganglioglioma
|
BRAF inhibitor + MEK inhibitor
C1
BRAF V600
|
Ganglioglioma
|
vemurafenib
C1
BRAF V600
|
Ganglioglioma
|
vemurafenib + cobimetinib
BRAF T599
C4
BRAF T599
|
Ganglioglioma
|
trametinib + dabrafenib
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
